Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Enteric Campylobacteriosis”

4 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 4 of 4 results

Large-scale testing (Phase 3)Study completedNCT02280044
What this trial is testing

Efficacy of Rifaximin in Preventing Campylobacteriosis

Who this might be right for
DysenteryDiarrheaEnteric Campylobacteriosis
Johns Hopkins Bloomberg School of Public Health 30
Large-scale testing (Phase 3)Study completedNCT03683667
What this trial is testing

Protein Plus: Improving Infant Growth Through Diet and Enteric Health

Who this might be right for
StuntingMalnutrition; ProteinEnteric Pathogens+1 more
Johns Hopkins Bloomberg School of Public Health 5,283
Not applicableStudy completedNCT02105714
What this trial is testing

Diagnosis of Neglected Tropical Diseases Among Patients With Persistent Digestive Disorders

Who this might be right for
Soil-transmitted HelminthiasisSchistosomiasisStrongyloidiasis+8 more
Swiss Tropical & Public Health Institute 2,800
Not applicableLooking for participantsNCT03223077
What this trial is testing

Mucosal and Microbiota Changes During Acute Campylobacteriosis

Who this might be right for
Irritable Bowel Syndrome
Mayo Clinic 150